Provide updates in the management of acute leukemia, myloproliferative neoplasms, AML, MDS, lymphoma, and myeloma |
|
|
|
|
|
Increased knowledge of the changing definitions of acute myeloid leukemia (AML) and myelodysplasia (MDS) |
|
|
|
|
|
Discuss the management of immunotherapies in myeloma and lymphoma |
|
|
|
|
|
Define the application of novel therapies for patients with blood cancers to improve their survival |
|
|
|
|
|